There’s an necessary replace on the James Gunn period of DC Studios movies, with a brand new title entering into the ring to script Warner Bros.’ Supergirl: Woman of Tomorrow.
Ana Nogueira has been employed to pen the Supergirl movie for the upcoming re-imagining of the DC heroine. The Hollywood Reporter broke the information and in addition revealed that Nogueira had been employed onto the Sasha Calle-led characteristic that was within the works earlier than The Flash got here and went. Calle was that movie’s standout and we hope that they’ll return to play this model of Kara, which is impressed by the Tom King run of comics that Nogueira is ready to adapt. Best recognized for the CW’s The Vampire Diaries, Nogueira can be a playwright and actress whose work on the final Supergirl script earned her an general writing take care of DC Studios.
DC head Gunn spoke to the hope that this tackle Kara Zor-El would stand aside from his upcoming Superman: Legacy movie. “Superman is a guy sent to Earth and raised by loving parents, where Supergirl in this story, she is a character raised on a chunk of Krypton,” THR quotes Gunn as saying in a video printed to what was then often known as Twitter. “She watched everybody around her perish in some terrible way, so she’s a much more jaded character.” More lately, he welcomed Nogueira to the mission on Instagram, which you’ll be able to see under: “A hearty public welcome to Ana Nogueira to the DC Studios family. Ana is an amazing writer whose screenplay adaptation of Woman of Tomorrow is above and beyond anything I hoped it would be. We’re excited to be moving forward on this unique take on Supergirl in this beautiful, star-spanning tale.”
Keep a watch on io9 for any updates relating to Supergirl: Woman of Tomorrow and extra DC Studios information.
Want extra io9 information? Check out when to anticipate the most recent Marvel, Star Wars, and Star Trek releases, what’s subsequent for the DC Universe on movie and TV, and every thing you could know concerning the future of Doctor Who.